What is the global market size of Bioresorbable Scaffolds Market?

Bioresorbable Scaffolds Market size was valued at USD 337.48 million in 2021 and is poised to grow from USD 374.94 million in 2022 to USD 870.31 million by 2030, growing at a CAGR of 11.1% in the forecast period (2023-2030).

Bioresorbable Scaffolds Companies

Q: Which region accounted for the largest share in Global Bioresorbable Scaffolds Market?

The dominance of the global bioresorbable scaffolds market stands with North America, attributed to several factors such as a significant population affected with cardiovascular diseases, a multitude of prominent companies operating in the region, and an increasing elderly demographic. Moreover, the rise in obesity and diabetes cases, sedentary lifestyles, heightened stress levels, and desk-bound routines have collectively propelled market growth. Following the Americas, Europe holds the second-largest market share, trailed by the Asia Pacific region. Notably, Asia Pacific stands out as the rapidly growing market due to its swift technological advancements and a substantial patient pool grappling with various vascular disorders. On the other hand, the Middle East & Africa region accounts for the least share in the global bioresorbable scaffolds market.

Bioresorbable Scaffolds Market Competitive Landscape

Bioresorbable Scaffolds Market Top Player’s Company Profile

Abbott

Medtronic

Boston Scientific Corporation

Biotronik

Elixir Medical Corporation

REVA Medical

Amaranth Medical

Kyoto Medical Planning

Xenogenics Corporation

B. Braun

Cardinal Health

Lombard Medical

Translumina

MicroPort Scientific Corporation

TERUMO CORPORATION

Bioresorbable Scaffolds Market

FAQs

Bioresorbable Scaffolds Market size was valued at USD 374.94 million in 2022 and is poised to grow from USD 416.56 million in 2023 to USD 966.92 million by 2031, growing at a CAGR of 11.10% during the forecast period (2024-2031).

The competitive landscape of the bioresorbable scaffolds market encompasses comprehensive insights into each competitor. These insights encompass various aspects, including an overview of the company, its financial standing, revenue generation, market potential, research and development investments, novel market strategies, reach, production facilities, capacities, strengths, weaknesses, product launches, breadth of offerings, and dominant applications. Notably, the information provided pertains solely to the strategic direction of these companies in the context of the bioresorbable scaffolds market. 'Abbott', 'Medtronic', 'Boston Scientific Corporation', 'Biotronik', 'Elixir Medical Corporation', 'REVA Medical', 'Amaranth Medical', 'Kyoto Medical Planning', 'Xenogenics Corporation', 'B. Braun', 'Cardinal Health', 'Lombard Medical', 'Translumina', 'MicroPort Scientific Corporation', 'TERUMO CORPORATION'

The escalating prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is a major driver for the bioresorbable scaffolds market. These conditions necessitate advanced treatments to restore blood flow, creating a demand for innovative solutions like bioresorbable scaffolds.

Increasing elderly population requires frequent healthcare services, driving the demand for bioresorbable scaffolds as older individuals are more susceptible to cardiovascular diseases.

The dominance of the bioresorbable scaffolds market stands with North America, attributed to several factors such as a significant population affected with cardiovascular diseases, a multitude of prominent companies operating in the region, and an increasing elderly demographic. Moreover, the rise in obesity and diabetes cases, sedentary lifestyles, heightened stress levels, and desk-bound routines have collectively propelled market growth. Following the Americas, Europe holds the second-largest market share, trailed by the Asia Pacific region. Notably, Asia Pacific stands out as the rapidly growing market due to its swift technological advancements and a substantial patient pool grappling with various vascular disorders. On the other hand, the Middle East & Africa region accounts for the least share in the bioresorbable scaffolds market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Bioresorbable Scaffolds Market Competitive Landscape

Bioresorbable Scaffolds Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Bioresorbable Scaffolds Market Competitive Landscape

Bioresorbable Scaffolds Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Bioresorbable Scaffolds Market?

Who are the key vendors in the Bioresorbable Scaffolds Market?

What is the key driver of Bioresorbable Scaffolds Market?

What is the key market trend for Bioresorbable Scaffolds Market?

Which region accounted for the largest share in Bioresorbable Scaffolds Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300